On 14 February 2022, Xlife Sciences successfully listed its shares on the standard “Sparks” of SIX Swiss Exchange — making it the very first listing on the new and regulated SME segment of SIX Swiss Exchange. Xlife Sciences focuses on the value development and commercialization of promising early-stage research projects from universities and other research institutions in the life sciences industry.